Ergomed Investor Relations Material
Latest events
H2 2022
Ergomed
H1 2023
26 Sep, 2023
H1 2023 TU
25 Jul, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ergomed plc
Access all reports
Ergomed plc provides specialized services to the pharmaceutical industry, including clinical trial management and pharmacovigilance. The company supports drug development through contract research and safety monitoring across a range of therapeutic areas. Its clients include biotech and pharmaceutical companies globally. The company is headquartered in Guildford, United Kingdom, and its shares are listed on the LSE.
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
ERGO
Country
🇬🇧 United Kingdom